High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Franzius
Christine
C
Schuck
Andreas
A
Bielack
Stefan S
SS
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000556:secondary*; D017024:Chemotherapy, Adjuvant; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012516:Osteosarcoma / Q000532:radiotherapy*; D010384:Pelvic Bones / Q000187:drug effects*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D012493:Samarium / Q000627:therapeutic use*; D016896:Treatment Outcome
D004164:Diphosphonates; D019275:Radiopharmaceuticals; C417557:propylenediaminetetramethylene phosphonate; D012493:Samarium